[go: up one dir, main page]

WO2020113485A1 - 调节肠道菌群的胶囊 - Google Patents

调节肠道菌群的胶囊 Download PDF

Info

Publication number
WO2020113485A1
WO2020113485A1 PCT/CN2018/119459 CN2018119459W WO2020113485A1 WO 2020113485 A1 WO2020113485 A1 WO 2020113485A1 CN 2018119459 W CN2018119459 W CN 2018119459W WO 2020113485 A1 WO2020113485 A1 WO 2020113485A1
Authority
WO
WIPO (PCT)
Prior art keywords
copies
servings
capsule
intestinal flora
regulating intestinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2018/119459
Other languages
English (en)
French (fr)
Inventor
陈惠�
郑惠华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JIANGSU ANHUI BIO-TECHNOLOGY Co Ltd
Original Assignee
JIANGSU ANHUI BIO-TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JIANGSU ANHUI BIO-TECHNOLOGY Co Ltd filed Critical JIANGSU ANHUI BIO-TECHNOLOGY Co Ltd
Priority to PCT/CN2018/119459 priority Critical patent/WO2020113485A1/zh
Publication of WO2020113485A1 publication Critical patent/WO2020113485A1/zh
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis

Definitions

  • the invention relates to a health food.
  • the object of the present invention is to provide a capsule for regulating intestinal flora.
  • a capsule for regulating intestinal flora characterized by being composed of the following parts by weight of raw materials:
  • the capsule for regulating intestinal flora is composed of the following parts by weight of raw materials:
  • the invention is rich in nutrients, has a variety of health-care nutrients, has excellent effects of regulating intestinal flora and maintaining intestinal function health, and is convenient to manufacture.
  • a capsule for regulating intestinal flora which is composed of the following parts by weight of raw materials:
  • a capsule for regulating intestinal flora which is composed of the following parts by weight of raw materials:
  • Bifidobacterium longum 10-20 copies (eg 10 copies, 15 copies, 20 copies)
  • Lactobacillus acidophilus 10-20 servings eg 10 servings, 15 servings, 20 servings.
  • Streptococcus thermophilus 10-20 servings eg 10 servings, 15 servings, 20 servings.
  • Bovine colostrum 10-20 copies (eg 10 copies, 15 copies, 20 copies)
  • Isomaltooligosaccharides 10-20 servings eg 10 servings, 15 servings, 20 servings.
  • Casein 10-20 copies eg 10 copies, 15 copies, 20 copies.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

一种调节肠道菌群的胶囊，由长双歧杆菌、嗜酸乳杆菌、嗜热链球菌、牛初乳、低聚异麦芽糖、酪蛋白组成。所述胶囊营养丰富，具有多种保健营养成分，具有优异的调节肠道菌群、保持肠道功能健康的效果，制作方便。

Description

调节肠道菌群的胶囊 技术领域
本发明涉及一种保健食品。
 背景技术
一些人群存在肠道菌群混乱、肠道功能差等现象，现有的保健品等这种现象的效果不理想。
 技术问题
本发明的目的在于提供一种调节肠道菌群的胶囊。
 技术解决方案
一种调节肠道菌群的胶囊，其特征是：由下列重量份的原料混合组成：
长双歧杆菌          10-20份
嗜酸乳杆菌          10-20份
嗜热链球菌          10-20份
牛初乳              10-20份
低聚异麦芽糖        10-20份
酪蛋白              10-20份。
所述的调节肠道菌群的胶囊，由下列重量份的原料混合组成：
长双歧杆菌          13份
嗜酸乳杆菌          15份
嗜热链球菌          18份
牛初乳              11份
低聚异麦芽糖        20份
酪蛋白              16份。
 有益效果
本发明营养丰富，具有多种保健营养成分，具有优异的调节肠道菌群、保持肠道功能健康的效果，制作方便。
 本发明的最佳实施方式
实施例1：
一种调节肠道菌群的胶囊，由下列重量份的原料混合组成：
长双歧杆菌          13份
嗜酸乳杆菌          15份
嗜热链球菌          18份
牛初乳              11份
低聚异麦芽糖        20份
酪蛋白              16份。
实施例2：
一种调节肠道菌群的胶囊，由下列重量份的原料混合组成：
长双歧杆菌          10-20份（例10份、15份、20份）
嗜酸乳杆菌          10-20份（例10份、15份、20份）
嗜热链球菌          10-20份（例10份、15份、20份）
牛初乳              10-20份（例10份、15份、20份）
低聚异麦芽糖        10-20份（例10份、15份、20份）
酪蛋白              10-20份（例10份、15份、20份）。

Claims (2)

  1. 一种调节肠道菌群的胶囊，其特征是：由下列重量份的原料混合组成：
    长双歧杆菌          10-20份
    嗜酸乳杆菌          10-20份
    嗜热链球菌          10-20份
    牛初乳              10-20份
    低聚异麦芽糖        10-20份
    酪蛋白              10-20份。
  2. 根据权利要求1所述的调节肠道菌群的胶囊，其特征是：由下列重量份的原料混合组成：
    长双歧杆菌          13份
    嗜酸乳杆菌          15份
    嗜热链球菌          18份
    牛初乳              11份
    低聚异麦芽糖        20份
    酪蛋白              16份。
PCT/CN2018/119459 2018-12-06 2018-12-06 调节肠道菌群的胶囊 Ceased WO2020113485A1 (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/CN2018/119459 WO2020113485A1 (zh) 2018-12-06 2018-12-06 调节肠道菌群的胶囊

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2018/119459 WO2020113485A1 (zh) 2018-12-06 2018-12-06 调节肠道菌群的胶囊

Publications (1)

Publication Number Publication Date
WO2020113485A1 true WO2020113485A1 (zh) 2020-06-11

Family

ID=70975218

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2018/119459 Ceased WO2020113485A1 (zh) 2018-12-06 2018-12-06 调节肠道菌群的胶囊

Country Status (1)

Country Link
WO (1) WO2020113485A1 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112568344A (zh) * 2020-12-10 2021-03-30 入圣生物科技无锡有限公司 一种可以调节肠道和增强免疫力的食品及其制备方法

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007031345A (ja) * 2005-07-27 2007-02-08 Seiko:Kk 腸内環境改善作用を有する食品組成物
CN101199299A (zh) * 2007-11-09 2008-06-18 湖南光大牧业科技有限公司 含共轭亚油酸的乳酸菌乳饮料及其生产方法
CN101366734A (zh) * 2008-06-18 2009-02-18 辽宁大生药业有限公司 合生素药物组合物
WO2009147157A1 (en) * 2008-06-05 2009-12-10 Dsm Ip Assets B.V. Instant yoghurt
CN102742659A (zh) * 2012-07-10 2012-10-24 陕西农产品加工技术研究院 一种益生菌羊奶片及其制备方法
CN103648510A (zh) * 2009-05-11 2014-03-19 雀巢产品技术援助有限公司 包含益生菌的口服营养补充物
CN107050062A (zh) * 2016-11-08 2017-08-18 江西益盟科技有限公司 治疗便秘的乳酸菌组合物及其制备方法

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007031345A (ja) * 2005-07-27 2007-02-08 Seiko:Kk 腸内環境改善作用を有する食品組成物
CN101199299A (zh) * 2007-11-09 2008-06-18 湖南光大牧业科技有限公司 含共轭亚油酸的乳酸菌乳饮料及其生产方法
WO2009147157A1 (en) * 2008-06-05 2009-12-10 Dsm Ip Assets B.V. Instant yoghurt
CN101366734A (zh) * 2008-06-18 2009-02-18 辽宁大生药业有限公司 合生素药物组合物
CN103648510A (zh) * 2009-05-11 2014-03-19 雀巢产品技术援助有限公司 包含益生菌的口服营养补充物
CN102742659A (zh) * 2012-07-10 2012-10-24 陕西农产品加工技术研究院 一种益生菌羊奶片及其制备方法
CN107050062A (zh) * 2016-11-08 2017-08-18 江西益盟科技有限公司 治疗便秘的乳酸菌组合物及其制备方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DU, YAJUN: "Growth-Prompoting Effect on Soluble Dietary Fibre to Intestinal Probiotics", CHINA DAIRY INDUSTRY, vol. 43, no. 7, 31 December 2015 (2015-12-31), pages 26 - 29, DOI: 20190820195820Y *
HE, SONG ET AL.: "Meta Analysis of Bifid-Preparations in Prevention of Secondary Diarrhea in Infants in China", CHINESE JOURNAL OF MICROECOLOGY, vol. 21, no. 8, 31 December 2009 (2009-12-31), pages 692 - 695, DOI: 20190820191117Y *
YANG, YANG ET AL.: "Probiotics Advantage Bacterium and the Best Ratio of the Probiotic Bacterias", FOOD SCIENCE AND TECHNOLOGY, vol. 38, no. 12, 31 December 2013 (2013-12-31), pages 19 - 22, DOI: 20190820190950Y *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112568344A (zh) * 2020-12-10 2021-03-30 入圣生物科技无锡有限公司 一种可以调节肠道和增强免疫力的食品及其制备方法

Similar Documents

Publication Publication Date Title
Gorreja et al. The potential role of adherence factors in probiotic function in the gastrointestinal tract of adults and pediatrics: a narrative review of experimental and human studies
MY203053A (en) Nutritional composition, food/drink composition using nutritional composition, and modified milk powder using nutritional composition
Patrignani et al. Use of Lactobacillus crispatus to produce a probiotic cheese as potential gender food for preventing gynaecological infections
Prajapati et al. Advances in probiotics research: mechanisms of action, health benefits, and limitations in applications
DK1359816T3 (da) Kombination af probiotika
SI1565547T1 (sl) Probiotiäśni sevi, postopek za izbiranje le-teh, njihovi sestavki in njihova uporaba
PH12018502406A1 (en) Nutritional composition comprising a probiotic for the prevention and/or treatment of anxiety disorders and related conditions in a mammal
MY207753A (en) Composition for maintenance and/or improvement of memory/learning ability, and food, medicine and feed each containing said composition
CN111084386A (zh) 一种具有改善肠道功能的益生菌补充剂
WO2020113485A1 (zh) 调节肠道菌群的胶囊
Gorlov et al. Synbiotic yoghurt with walnut and cereal brittle added as a next‐generation bioactive compound: Development and characteristics
MX2017012376A (es) Tortilla nutraceutica de harina fermentada, y proceso para obtencion de la misma.
JP2020513780A5 (zh)
RU2018124842A (ru) Применение крахмала для повышения качества приготовления сцеженного ферментированного молочного продукта
MX2025012912A (es) Composicion nutricional
WO2020113495A1 (zh) 灵芝孢子油软胶囊
Zirker Probiotic use in chronic kidney disease patients
Solomon New aspects of the production of fergated dairy products with probiotic properties
Kabiri et al. Inhibitiory properties of cytoplasmic extract of Lactobacilli isolated from common carp intestine on human chronic myelocytic leukemia K562 cell line: an in vitro study.
Qian et al. Alterations in the gut microbiota of toddlers with cow milk protein allergy treated with a partially hydrolyzed formula containing synbiotics: A nonrandomized controlled interventional study
JP2019170245A (ja) 山羊乳由来の粉乳とビフィドバクテリウム属細菌及び／又は乳酸菌とを含む組成物
CN107874262A (zh) 一种复合乳酸菌多肽粉
Steyn A matter of the gut
WO2020113494A1 (zh) 改善睡眠保健胶囊
UA114574C2 (uk) Склад їстівної плівки з пробіотиком

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18942321

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18942321

Country of ref document: EP

Kind code of ref document: A1